The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of topics including formulation platforms, AI, amorphous solid dispersions, and animal studies.
|Articles|April 15, 2015
Loading Receiver Expands Versatility
VAC-U-MAX sanitary receivers handle pharmaceutical powders.
Advertisement
VAC-U-MAX sanitary pharmaceutical receivers are designed for loading tablet press machines, blenders, mix tanks, and loss-in-weight feeder refill with free-flowing or non-free flowing powders and APIs. The units are made of stainless steel and convey at rates of 500 to 5000 pounds per hour or more. The units are available with bead blast, satin, or mirror polish.
VAC-U-MAX
Advertisement
Related to this article
Subathra Ramamoorthy, Veranova, on when to escalate to structural elucidation and pair orthogonal techniques when characterizing an impurity.
Manish Baviskar, Hubot CDMO, on ALCOA++ data integrity, model version change control, continuous monitoring, and human sign-off.
The agreement between CDER and OII with allow for coordinated marketing application assessments and inspections.
Manish Baviskar, Hubot CDMO, explains which AI skills validation engineers need first and why AI model updates must go through GMP change control.
Ron Filler, Drug Development Consultants, explains how USP's 1074 revision brings human-relevant safety science to formulators and excipient makers.
Nitin Kumar Swarnakar, PhD, global application lab manager at BASF, talks about spray drying for drying amorphous solid dispersions and Raman spectroscopy’s role as a quantitative analytical tool.
Aleksandra Zuraw, senior veterinary pathologist at Charles River, discusses how chain of custody, good laboratory practice, quality control, and validation are applied to digital pathology data used in drug development.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
AI Formulation: Regulators Want Data
2
FDA’s New Inspection Playbook Counts Remote Assessments and MRA Reports Toward Facility Evaluations
3
USP 1074 Revises Excipient Safety: AAPS PharmSci 360 2026
4
Late-Phase Impurities Need Reference Standards: AAPS PharmSci 360 2026
5